139 related articles for article (PubMed ID: 18356801)
21. Psychotic episode in a patient with Alzheimer's dementia while shifting from the oral to patch form of rivastigmine.
Ku SC; Hsu CC; Chang HA; Kao YC; Tzeng NS
J Neuropsychiatry Clin Neurosci; 2014; 26(3):E51-2. PubMed ID: 25093791
[No Abstract] [Full Text] [Related]
22. Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease.
Winblad B; Kawata AK; Beusterien KM; Thomas SK; Wimo A; Lane R; Fillit H; Blesa R
Int J Geriatr Psychiatry; 2007 May; 22(5):485-91. PubMed ID: 17407176
[TBL] [Abstract][Full Text] [Related]
23. A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.
Cummings J; Winblad B
Expert Rev Neurother; 2007 Nov; 7(11):1457-63. PubMed ID: 17997695
[TBL] [Abstract][Full Text] [Related]
24. A study of rivastigmine liposomes for delivery into the brain through intranasal route.
Arumugam K; Subramanian GS; Mallayasamy SR; Averineni RK; Reddy MS; Udupa N
Acta Pharm; 2008 Sep; 58(3):287-97. PubMed ID: 19103565
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review.
Kurz A; Farlow M; Lefèvre G
Int J Clin Pract; 2009 May; 63(5):799-805. PubMed ID: 19392927
[TBL] [Abstract][Full Text] [Related]
26. Rivastigmine in Parkinson's disease dementia.
Chitnis S; Rao J
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
[TBL] [Abstract][Full Text] [Related]
27. [A transdermal patch of rivastigmine (Exelon)].
Salmon E
Rev Med Liege; 2008 Sep; 63(9):570-1. PubMed ID: 19051514
[TBL] [Abstract][Full Text] [Related]
28. [Rivastigmine against dementia in Parkinson disease?].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
[No Abstract] [Full Text] [Related]
29. Transdermal rivastigmine: management of cutaneous adverse events and review of the literature.
Greenspoon J; Herrmann N; Adam DN
CNS Drugs; 2011 Jul; 25(7):575-83. PubMed ID: 21623641
[TBL] [Abstract][Full Text] [Related]
30. Acute dystonic reaction with rivastigmine.
Dhikav V; Anand KS
Int Psychogeriatr; 2013 Aug; 25(8):1385-6. PubMed ID: 23561545
[TBL] [Abstract][Full Text] [Related]
31. Benefits of rivastigmine on attention in dementia associated with Parkinson disease.
Wesnes KA; McKeith I; Edgar C; Emre M; Lane R
Neurology; 2005 Nov; 65(10):1654-6. PubMed ID: 16301500
[TBL] [Abstract][Full Text] [Related]
32. High-dose cholinergic therapy with rivastigmine patch does not prolong QTc time in patients with Alzheimer's disease.
Riepe MW
J Clin Psychiatry; 2014 Mar; 75(3):288. PubMed ID: 24717382
[No Abstract] [Full Text] [Related]
33. Rivastigmine patch and massage for Alzheimer's disease patients.
Satoh S; Kajiwara M; Kiyokawa E; Toukairin Y; Fujii M; Sasaki H
Geriatr Gerontol Int; 2013 Apr; 13(2):515-6. PubMed ID: 23551354
[No Abstract] [Full Text] [Related]
34. Rivastigmine transdermal patch: in the treatment of dementia of the Alzheimer's type.
Yang LP; Keating GM
CNS Drugs; 2007; 21(11):957-65. PubMed ID: 17927299
[No Abstract] [Full Text] [Related]
35. Sinus arrest as a result of rivastigmine in an elderly dementia with Lewy bodies patient.
Muto S; Kawano H; Nakatomi D; Yamasa T; Maemura K
Geriatr Gerontol Int; 2015 Feb; 15(2):229-30. PubMed ID: 25619267
[No Abstract] [Full Text] [Related]
36. Cholinergic balance in dementia with Lewy bodies: reversible worsening of Parkinsonism at rivastigmine dosage modulation.
Clerici F; Ratti PL; Pomati S; Maggiore L; Elia A; Mariani C
Neurol Sci; 2007 Oct; 28(5):282-4. PubMed ID: 17972045
[TBL] [Abstract][Full Text] [Related]
37. Rivastigmine transdermal patch: role in the management of Alzheimer's disease.
Guay DR
Consult Pharm; 2008 Aug; 23(8):598-609. PubMed ID: 19032006
[TBL] [Abstract][Full Text] [Related]
38. Improvement in behavioral and psychological symptoms of dementia by rivastigmine patch in a group of Italian elderly patients with Alzheimer's disease.
Servello A; Ettorre E; Cacciafesta M
Panminerva Med; 2017 Sep; 59(3):275-277. PubMed ID: 28665099
[No Abstract] [Full Text] [Related]
39. [A comparative study of the effectiveness and tolerability of a procedure involving slow dose-escalation of rivastigmine in patients with mild or moderate Alzheimer-type dementia: the SCALEX study].
Agüera-Ortiz LF; Ramos-García M; Gobartt AL;
Rev Neurol; 2008 May 1-15; 46(9):517-24. PubMed ID: 18446692
[TBL] [Abstract][Full Text] [Related]
40. Rivastigmine for dementia associated with Parkinson's disease.
Harada CN; Shega JW; Sachs GA
N Engl J Med; 2005 Mar; 352(13):1387; author reply 1387. PubMed ID: 15800242
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
